CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-06-27 was $112.44M, a 1556.65% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-03-28 was $208.28M, a 41.02% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-09-27 was $93.00K, a 99.91% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-06-28 was $6.79M, a 23.86% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for fiscal 2025 was $360.11M, a 202.17% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for fiscal 2024 was $119.17M, a 393.38% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for fiscal 2023 was $24.16M, a 37.50% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. treasury stock, value, acquired, cost method for fiscal 2022 was $38.65M, a 5.05% decline from fiscal 2021.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-27 | $112.44M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $208.28M 10-Q · filed 2026-08-05 | |
| 2025-12-27 | $360.11M 10-K · filed 2026-02-18 | |
| 2025-09-27 | $93.00K 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $6.79M 10-Q · filed 2026-08-05 | |
| 2025-03-29 | $353.13M 10-Q · filed 2026-08-05 | |
| 2024-12-28 | $119.17M 10-K · filed 2026-02-18 | |
| 2024-09-28 | $100.79M 10-Q · filed 2025-11-05 | |
| 2024-06-29 | $8.91M 10-Q · filed 2025-11-05 | |
| 2024-03-30 | $9.35M 10-Q · filed 2025-11-05 | |
| 2023-12-30 | $24.16M 10-K · filed 2026-02-18 | |
| 2023-09-30 | $38.00K 10-Q · filed 2024-11-06 | |
| 2023-07-01 | $4.97M 10-Q · filed 2024-11-06 | |
| 2023-04-01 | $19.01M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $38.65M 10-K · filed 2025-02-19 | |
| 2022-09-24 | $24.00K 10-Q · filed 2023-11-08 | |
| 2022-06-25 | $4.47M 10-Q · filed 2023-11-08 | |
| 2022-03-26 | $33.99M 10-Q · filed 2023-11-08 | |
| 2021-12-25 | $40.71M 10-K · filed 2024-02-14 | |
| 2021-09-25 | $143.00K 10-Q · filed 2022-11-02 | |
| 2021-06-26 | $4.27M 10-Q · filed 2022-11-02 | |
| 2021-03-27 | $36.03M 10-Q · filed 2022-11-02 | |
| 2020-12-26 | $23.98M 10-K · filed 2023-02-22 | |
| 2020-09-26 | $112.00K 10-Q · filed 2021-11-03 | |
| 2020-06-27 | $118.00K 10-Q · filed 2021-11-03 | |
| 2020-03-28 | $23.68M 10-Q · filed 2021-11-03 | |
| 2019-12-28 | $18.09M 10-K · filed 2022-02-16 | |
| 2019-09-28 | $156.00K 10-Q · filed 2020-10-29 | |
| 2019-06-29 | $123.00K 10-Q · filed 2020-10-29 | |
| 2019-03-30 | $17.76M 10-Q · filed 2020-10-29 | |
| 2018-12-29 | $13.85M 10-K · filed 2021-02-17 | |
| 2018-09-29 | $123.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $119.00K 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $13.55M 10-Q · filed 2019-11-06 | |
| 2017-12-30 | $106.91M 10-K · filed 2020-02-11 | |
| 2016-12-31 | $12.27M 10-K · filed 2019-02-13 | |
| 2015-12-26 | $117.48M 10-K · filed 2018-02-13 | |
| 2014-12-27 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $117.38M 10-K · filed 2017-02-14 |
| 2014-09-27 | $20.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $194.55M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $80.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $239.69M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $16.47M 10-Q · filed 2014-04-30 | $175.82M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $77.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $170.27M 10-K · filed 2016-02-12 |
| 2013-09-28 | $65.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$17.26M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $16.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | -$67.75M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | $10.93M 10-Q · filed 2013-05-08 | -$69.04M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | -$110.33M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$64.49M 10-K · filed 2015-02-17 |
| 2012-09-29 | $15.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$468.47M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $15.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$419.70M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $15.48M 10-Q · filed 2012-05-04 | -$414.50M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | -$514.31M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$269.65M 10-K · filed 2014-02-25 |
| 2011-09-24 | $63.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$308.52M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $20.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$120.28M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $160.32M 10-Q · filed 2011-05-04 | |
| 2010-12-25 | -$553.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$298.17M 10-K · filed 2013-02-27 |
| 2010-09-25 | $252.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | |
| 2009-12-26 | $44.60M 10-K · filed 2012-02-27 | |
| 2008-12-27 | $115.55M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |